425 related articles for article (PubMed ID: 16374884)
1. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children.
Hourani R; Horská A; Albayram S; Brant LJ; Melhem E; Cohen KJ; Burger PC; Weingart JD; Carson B; Wharam MD; Barker PB
J Magn Reson Imaging; 2006 Feb; 23(2):99-107. PubMed ID: 16374884
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
3. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
4. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
5. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
6. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
7. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
9. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].
Zhou GF; Wang XY; Gong CG; Liu F; Wang RW
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1342-4. PubMed ID: 18753055
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopic imaging in the border zone of gliomas: correlation of metabolic and histological changes at low tumor infiltration--initial results.
Stadlbauer A; Nimsky C; Buslei R; Pinker K; Gruber S; Hammen T; Buchfelder M; Ganslandt O
Invest Radiol; 2007 Apr; 42(4):218-23. PubMed ID: 17351427
[TBL] [Abstract][Full Text] [Related]
11. Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults?
Hourani R; Brant LJ; Rizk T; Weingart JD; Barker PB; Horská A
AJNR Am J Neuroradiol; 2008 Feb; 29(2):366-72. PubMed ID: 18055564
[TBL] [Abstract][Full Text] [Related]
12. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
[TBL] [Abstract][Full Text] [Related]
13. MR spectroscopic evaluation of brain tissue damage after treatment for pediatric brain tumors.
Blamek S; Larysz D; Ficek K; Sokół M; Miszczyk L; Tarnawski R
Acta Neurochir Suppl; 2010; 106():183-6. PubMed ID: 19812945
[TBL] [Abstract][Full Text] [Related]
14. Role of in vivo proton MR spectroscopy in the evaluation of adult brain lesions: our preliminary experience.
Kumar A; Kaushik S; Tripathi RP; Kaur P; Khushu S
Neurol India; 2003 Dec; 51(4):474-8. PubMed ID: 14742925
[TBL] [Abstract][Full Text] [Related]
15. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopic imaging in pediatric low-grade gliomas.
Porto L; Kieslich M; Franz K; Lehrbecher T; Pilatus U; Hattingen E
Brain Tumor Pathol; 2010 Oct; 27(2):65-70. PubMed ID: 21046307
[TBL] [Abstract][Full Text] [Related]
17. Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers.
Marcus KJ; Astrakas LG; Zurakowski D; Zarifi MK; Mintzopoulos D; Poussaint TY; Anthony DC; De Girolami U; Black PM; Tarbell NJ; Tzika AA
Int J Oncol; 2007 Mar; 30(3):651-7. PubMed ID: 17273766
[TBL] [Abstract][Full Text] [Related]
18. Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.
Chawla S; Oleaga L; Wang S; Krejza J; Wolf RL; Woo JH; O'Rourke DM; Judy KD; Grady MS; Melhem ER; Poptani H
J Neuroimaging; 2010 Jan; 20(1):3-8. PubMed ID: 19021846
[TBL] [Abstract][Full Text] [Related]
19. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors.
Astrakas LG; Zurakowski D; Tzika AA; Zarifi MK; Anthony DC; De Girolami U; Tarbell NJ; Black PM
Clin Cancer Res; 2004 Dec; 10(24):8220-8. PubMed ID: 15623597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
